Improved locus-specific database for OPA1 mutations allows inclusion of advanced clinical data
- PMID: 25243597
- DOI: 10.1002/humu.22703
Improved locus-specific database for OPA1 mutations allows inclusion of advanced clinical data
Abstract
Autosomal-dominant optic atrophy (ADOA) is the most common inherited optic neuropathy, due to mutations in the optic atrophy 1 gene (OPA1) in about 60%-80% of cases. At present, the clinical heterogeneity of patients carrying OPA1 variants renders genotype-phenotype correlations difficulty. Since 2005, when we published the first locus-specific database (LSDB) dedicated to OPA1, a large amount of new clinical and genetic knowledge has emerged, prompting us to update this database. We have used the Leiden Open-Source Variation Database to develop a clinico-biological database, aiming to add clinical phenotypes related to OPA1 variants. As a first step, we validated this new database by registering several patients previously reported in the literature, as well as new patients from our own institution. Contributors may now make online submissions of clinical and molecular descriptions of phenotypes due to OPA1 variants, including detailed ophthalmological and neurological data, with due respect to patient anonymity. The updated OPA1 LSDB (http://opa1.mitodyn.org/) should prove useful for molecular diagnoses, large-scale variant statistics, and genotype-phenotype correlations in ADOA studies.
Keywords: LSDB; OPA1; eOPA1; locus-specific database; optic atrophy 1.
© 2014 WILEY PERIODICALS, INC.
Similar articles
-
OPA1: 516 unique variants and 831 patients registered in an updated centralized Variome database.Orphanet J Rare Dis. 2019 Sep 10;14(1):214. doi: 10.1186/s13023-019-1187-1. Orphanet J Rare Dis. 2019. PMID: 31500643 Free PMC article.
-
eOPA1: an online database for OPA1 mutations.Hum Mutat. 2005 May;25(5):423-8. doi: 10.1002/humu.20161. Hum Mutat. 2005. PMID: 15832306
-
Dominant optic atrophy, sensorineural hearing loss, ptosis, and ophthalmoplegia: a syndrome caused by a missense mutation in OPA1.Am J Ophthalmol. 2004 Nov;138(5):749-55. doi: 10.1016/j.ajo.2004.06.011. Am J Ophthalmol. 2004. PMID: 15531309
-
Recessive optic atrophy, sensorimotor neuropathy and cataract associated with novel compound heterozygous mutations in OPA1.Mol Med Rep. 2016 Jul;14(1):33-40. doi: 10.3892/mmr.2016.5209. Epub 2016 May 4. Mol Med Rep. 2016. PMID: 27150940 Free PMC article. Review.
-
[Not only optic neuropathy: new molecular and clinical aspects of OPA1 gene mutations].Klin Oczna. 2014;116(1):52-8. Klin Oczna. 2014. PMID: 25137924 Review. Polish.
Cited by
-
Short-form OPA1 is a molecular chaperone in mitochondrial intermembrane space.Sci China Life Sci. 2022 Feb;65(2):227-235. doi: 10.1007/s11427-021-1962-0. Epub 2021 Aug 31. Sci China Life Sci. 2022. PMID: 34480695
-
OPA1: 516 unique variants and 831 patients registered in an updated centralized Variome database.Orphanet J Rare Dis. 2019 Sep 10;14(1):214. doi: 10.1186/s13023-019-1187-1. Orphanet J Rare Dis. 2019. PMID: 31500643 Free PMC article.
-
CRISPR-Cas9 correction of OPA1 c.1334G>A: p.R445H restores mitochondrial homeostasis in dominant optic atrophy patient-derived iPSCs.Mol Ther Nucleic Acids. 2021 Aug 19;26:432-443. doi: 10.1016/j.omtn.2021.08.015. eCollection 2021 Dec 3. Mol Ther Nucleic Acids. 2021. PMID: 34589289 Free PMC article.
-
Mutation Screening of mtDNA Combined Targeted Exon Sequencing in a Cohort With Suspected Hereditary Optic Neuropathy.Transl Vis Sci Technol. 2020 Jul 8;9(8):11. doi: 10.1167/tvst.9.8.11. eCollection 2020 Jul. Transl Vis Sci Technol. 2020. PMID: 32855858 Free PMC article.
-
Fast and deep phosphoproteome analysis with the Orbitrap Astral mass spectrometer.Nat Commun. 2024 Aug 15;15(1):7016. doi: 10.1038/s41467-024-51274-0. Nat Commun. 2024. PMID: 39147754 Free PMC article.
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
